Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients (ERCO-Park)

Toulouse University Hospital

Status: Completed

Conditions: COVID; Parkinson Disease

Treatments: Other: Questionnaire and interview

Study type: Observational

Funder types: Other

Identifiers

NCT04466839

RC31/20/0193

Details and patient eligibility

About

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

Full description

Adaptation capacities are necessary to cope with the brutal and drastic changes imposed by the pandemic and its consequences. In Parkinson's disease, where there are routine situations with difficulties adjusting to newness, patients in the current situation may be particularly affected and present anxiety due to great difficulties in adaptation.

The repercussions in terms of symptoms (motor and non-motor) of the disease could be very significant. In this population already widely exposed to anxio-depressive symptoms (depression being a common symptom of Parkinson's disease, affecting up to 30 to 40% of patients outside of crisis periods), we can expect a risk increased psychiatric decompensation. The psychiatric consequences could not be limited to the current period but also concern long-term patients, in particular if there is decompensation of other symptoms of the disease (motors, complications linked to treatment, etc.).

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

This is an observational, French multicenter study, of an uncontrolled cohort of parkinsonian patients followed by doctors from Parkinson Expert Centers in hospitals.

Enrollment: 411 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient followed by a doctor from the Parkinson Expert Center of the Toulouse University Hospital, Lille, Paris, Rouen, Nimes, Reims, Besancon, Marseille
• And with idiopathic Parkinson's disease
• Patients hospitalized or in consultation between 16/03/2020 and 16/05/2020.

Exclusion criteria

• Atypical parkinsonian syndrome
• Patient subject to a legal protection order (tutorship)
• Patient not wishing to answer questions

Trial design

411 participants in 1 patient group

parkinsonian patients

Description:

Cohort of parkinsonian patients followed by doctors from the Parkinson Expert Centers in teaching hospitals.

Treatment:

Other: Questionnaire and interview